XRTX — XORTX Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapSucker Stock

Annual balance sheet for XORTX Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	R2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	Interim Report	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	fx Final	fx Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	1.57	14.9	10.4	3.45	2.47
Net Total Accounts Receivable
Net Total Receivables	0.046	0.041	0.082	0.061	0.018
Prepaid Expenses
Total Other Current Assets
Total Current Assets	1.62	16	10.9	4.07	2.68
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0	—	0.093	0.024	0.035
Net Intangible Assets
Long Term Investments
Total Assets	1.8	17.4	12.4	5.47	4.09
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	0.812	0.555	1.52	0.295	0.758
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	0.812	4.19	5.38	0.826	0.758
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	0.987	13.2	7	4.64	3.34
Total Liabilities & Shareholders' Equity	1.8	17.4	12.4	5.47	4.09
Total Common Shares Outstanding